Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada ; volume:25 ; number:9 ; day:8 ; month:5 ; year:2014 ; pages:2323-2324 ; date:9.2014
Osteoporosis international ; 25, Heft 9 (8.5.2014), 2323-2324, 9.2014
- Urheber
-
Sugimoto, T.
Nakamura, T.
Nakamura, Y.
Isogai, Y.
Shiraki, M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-014-2722-5
- URN
-
urn:nbn:de:101:1-2019102708493705355209
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sugimoto, T.
- Nakamura, T.
- Nakamura, Y.
- Isogai, Y.
- Shiraki, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Postmenopausal osteoporosis
Quality of life in post-menopausal osteoporosis
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Interaction between bone and immune cells : Implications for postmenopausal osteoporosis
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis
Postmenopausal osteoporosis
Quality of life in post-menopausal osteoporosis
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Interaction between bone and immune cells : Implications for postmenopausal osteoporosis
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis
Postmenopausal osteoporosis
Quality of life in post-menopausal osteoporosis
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Concerns on modeling postmenopausal osteoporosis on young female rats
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Interaction between bone and immune cells : Implications for postmenopausal osteoporosis
Determinants of imminent fracture risk in postmenopausal women with osteoporosis